CURRENT Medical Diagnosis and
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Part A — Ch. 1: Disease Prevention & Health Promotion (5
items)
1)
Reference
Ch. 1 — Disease Prevention & Health Promotion
,Question Stem
A 54-year-old man with no prior colon disease asks about
colorectal cancer screening. He has average risk and is fearful of
colonoscopy. Which strategy best balances effectiveness and
patient adherence for colorectal cancer screening?
Options
A. Recommend colonoscopy every 10 years only.
B. Offer stool-based testing (annual FIT) as an alternative to
colonoscopy.
C. Recommend no screening until age 60 if he prefers
noninvasive tests.
D. Suggest sigmoidoscopy every 10 years as equivalent to
colonoscopy.
Correct Answer
B
Rationales
• Correct (B): Stool-based testing such as annual FIT is an
evidence-based, guideline-supported alternative for
average-risk adults who decline colonoscopy; it increases
adherence while still enabling detection of advanced
neoplasia. (CMDT emphasizes offering acceptable,
evidence-based alternatives to improve screening uptake.)
accessmedicine.mhmedical.com
, • Incorrect (A): Colonoscopy every 10 years is highly
effective but may reduce adherence for patients unwilling
to undergo invasive testing.
• Incorrect (C): Delaying screening until 60 without meeting
guideline criteria increases risk of missed early cancers;
screening should start at recommended ages for average-
risk adults.
• Incorrect (D): Flexible sigmoidoscopy is less sensitive for
proximal lesions and is not equivalent to colonoscopy for
comprehensive CRC screening.
Teaching Point
Offer acceptable screening alternatives (e.g., FIT) to improve
adherence and detection.
Citation (Simplified APA)
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
accessmedicine.mhmedical.com
2)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Question Stem
A 68-year-old woman with well-controlled type 2 diabetes asks
whether high-dose statin therapy is indicated purely for primary
, prevention based on age. Which best reflects preventive
decision-making?
Options
A. Age alone (>65) mandates high-intensity statin for everyone.
B. Use shared decision-making; assess 10-year ASCVD risk and
comorbidities before starting statin intensity.
C. Avoid statins in all adults over 65 because of side effects.
D. Initiate aspirin for primary prevention instead of statin.
Correct Answer
B
Rationales
• Correct (B): CMDT emphasizes individualized, risk-based
preventive therapy: use cardiovascular risk estimation and
consider comorbidities, medication tolerance, and patient
preference when choosing statin intensity.
accessmedicine.mhmedical.com
• Incorrect (A): Age alone does not automatically mandate
high-intensity statin without risk assessment and
tolerability considerations.
• Incorrect (C): Statins can benefit many older adults when
indicated; blanket avoidance is not guideline-based.
• Incorrect (D): Aspirin is not routinely recommended for
primary prevention in older adults because of bleeding
risk; it is not a substitute for risk-based statin therapy.
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
Part A — Ch. 1: Disease Prevention & Health Promotion (5
items)
1)
Reference
Ch. 1 — Disease Prevention & Health Promotion
,Question Stem
A 54-year-old man with no prior colon disease asks about
colorectal cancer screening. He has average risk and is fearful of
colonoscopy. Which strategy best balances effectiveness and
patient adherence for colorectal cancer screening?
Options
A. Recommend colonoscopy every 10 years only.
B. Offer stool-based testing (annual FIT) as an alternative to
colonoscopy.
C. Recommend no screening until age 60 if he prefers
noninvasive tests.
D. Suggest sigmoidoscopy every 10 years as equivalent to
colonoscopy.
Correct Answer
B
Rationales
• Correct (B): Stool-based testing such as annual FIT is an
evidence-based, guideline-supported alternative for
average-risk adults who decline colonoscopy; it increases
adherence while still enabling detection of advanced
neoplasia. (CMDT emphasizes offering acceptable,
evidence-based alternatives to improve screening uptake.)
accessmedicine.mhmedical.com
, • Incorrect (A): Colonoscopy every 10 years is highly
effective but may reduce adherence for patients unwilling
to undergo invasive testing.
• Incorrect (C): Delaying screening until 60 without meeting
guideline criteria increases risk of missed early cancers;
screening should start at recommended ages for average-
risk adults.
• Incorrect (D): Flexible sigmoidoscopy is less sensitive for
proximal lesions and is not equivalent to colonoscopy for
comprehensive CRC screening.
Teaching Point
Offer acceptable screening alternatives (e.g., FIT) to improve
adherence and detection.
Citation (Simplified APA)
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
accessmedicine.mhmedical.com
2)
Reference
Ch. 1 — Disease Prevention & Health Promotion
Question Stem
A 68-year-old woman with well-controlled type 2 diabetes asks
whether high-dose statin therapy is indicated purely for primary
, prevention based on age. Which best reflects preventive
decision-making?
Options
A. Age alone (>65) mandates high-intensity statin for everyone.
B. Use shared decision-making; assess 10-year ASCVD risk and
comorbidities before starting statin intensity.
C. Avoid statins in all adults over 65 because of side effects.
D. Initiate aspirin for primary prevention instead of statin.
Correct Answer
B
Rationales
• Correct (B): CMDT emphasizes individualized, risk-based
preventive therapy: use cardiovascular risk estimation and
consider comorbidities, medication tolerance, and patient
preference when choosing statin intensity.
accessmedicine.mhmedical.com
• Incorrect (A): Age alone does not automatically mandate
high-intensity statin without risk assessment and
tolerability considerations.
• Incorrect (C): Statins can benefit many older adults when
indicated; blanket avoidance is not guideline-based.
• Incorrect (D): Aspirin is not routinely recommended for
primary prevention in older adults because of bleeding
risk; it is not a substitute for risk-based statin therapy.
